Location History:
- Redwood City, CA (US) (1996)
- Hillsborough, CA (US) (2001 - 2010)
Company Filing History:
Years Active: 1996-2010
Title: The Innovations of Michael George Mulkerrin
Introduction
Michael George Mulkerrin is a prominent inventor based in Hillsborough, California. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide variants. With a total of eight patents to his name, Mulkerrin's work has had a substantial impact on the industry.
Latest Patents
Mulkerrin's latest patents focus on polypeptide variants that comprise a human IgG Fc region. These variants include amino acid substitutions at specific positions, which result in altered effector functions. For instance, the binding affinity for human C1q and complement-dependent cytotoxicity (CDC) activity may be enhanced in these variant polypeptides. His innovative approach aims to improve the efficacy of therapeutic proteins by optimizing their interactions with immune components.
Career Highlights
Mulkerrin is currently employed at Genentech, Inc., a leading biotechnology company known for its groundbreaking work in pharmaceuticals. His role at Genentech has allowed him to collaborate with other talented professionals in the field, further advancing his research and innovations.
Collaborations
Some of Mulkerrin's notable coworkers include Esohe Ekinaduese Idusogie and Leonard G Presta. Their collaborative efforts contribute to the ongoing advancements in biotechnology and the development of new therapeutic solutions.
Conclusion
Michael George Mulkerrin's contributions to the field of biotechnology through his innovative polypeptide variants demonstrate his commitment to advancing medical science. His work continues to influence the development of effective therapies, showcasing the importance of innovation in healthcare.